The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials
Conclusions Sulfonylureas are not associated with increased risk for all-cause mortality, cardiovascular mortality, myocardial infarction, or stroke. Current evidence supports the safety of sulfonylureas; an absolute risk of 0.5% could be firmly discarded. Review registration PROSPERO CRD42014004330
Source: PLoS Medicine - Category: Internal Medicine Authors: Dimitris Varvaki Rados Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Attack | Internal Medicine | Stroke | Study